If you’ve had a C. difficile infection, you may have some questions,
and a lot of frustration. You’re not alone. Nearly half a million people in the US are affected every year.
That is why we at Ferring are so committed to developing microbiome-based therapies for recurrent C. diff infections.
We’ll have much more to share soon. Please sign up to be the first to hear about it.
This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various
products
that
may be of interest to Ferring's employees and customers, as well as to members of the health care community
and
the
general public. Please feel free to browse this web site. Your access and use of the information contained
herein is
subject to the following terms and conditions and all applicable laws. By accessing and browsing this web
site,
you
accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede
any
other agreement between you and Ferring. All information on this site is intended for US audiences only.
©2020 Ferring B.V. US-MBIO-2000006
This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various
products
that may be of interest to Ferring's employees and customers, as well as to members of the health care
community
and the general public. Please feel free to browse this web site. Your access and use of the information
contained herein is subject to the following terms and conditions and all applicable laws. By accessing
and
browsing this web site, you accept, without limitation or qualification, these terms and conditions and
acknowledge that they supersede any other agreement between you and Ferring. All information on this
site
is
intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100090
This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100164This site is intended for users in the United States.
This website provides general information about Ferring in the United States. For information about the global company or its products in another specific country, please select your area of interest under "Ferring Worldwide" above. FERRING, the FERRING PHARMACEUTICALS logo and other Ferring product trade names are trademarks of Ferring B.V. Notwithstanding this disclaimer, all other names and marks mentioned in this website are the trade names, trademarks or service marks of their respective owners.
©2022 Ferring B.V. US-MBIO-2200120
This site is intended for users in the United States.
This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this website. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this website, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only.
©2022 Ferring B.V. US-MBIO-2100227